본문으로 건너뛰기
← 뒤로

Early Activation of a Multilevel Prostate Cancer Screening Model: Pilot Phase Results and Strategic Perspectives in Lombardy Region.

1/5 보강
Healthcare (Basel, Switzerland) 📖 저널 OA 100% 2021: 2/2 OA 2022: 5/5 OA 2023: 15/15 OA 2024: 4/4 OA 2025: 34/34 OA 2026: 23/23 OA 2021~2026 2025 Vol.13(16)
Retraction 확인
출처

Azzolini E, Cereda D, Piccinelli S, Viscardi M, Deandrea S

📝 환자 설명용 한 줄

: Prostate cancer is the most frequently diagnosed cancer among men in Italy, yet no national population-based screening program exists.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Azzolini E, Cereda D, et al. (2025). Early Activation of a Multilevel Prostate Cancer Screening Model: Pilot Phase Results and Strategic Perspectives in Lombardy Region.. Healthcare (Basel, Switzerland), 13(16). https://doi.org/10.3390/healthcare13162041
MLA Azzolini E, et al.. "Early Activation of a Multilevel Prostate Cancer Screening Model: Pilot Phase Results and Strategic Perspectives in Lombardy Region.." Healthcare (Basel, Switzerland), vol. 13, no. 16, 2025.
PMID 40868657 ↗

Abstract

: Prostate cancer is the most frequently diagnosed cancer among men in Italy, yet no national population-based screening program exists. In response to new European Council recommendations, the Lombardy Region launched a pilot in November 2024 to assess the feasibility of a digitally enabled, risk-adapted screening model. : Men turning 50 were invited to voluntarily self-enroll through the regional electronic health record (FSE). A digital questionnaire assessed eligibility and family history (FH); eligible individuals (97,849 men without a PSA test in the past two years in the regional database) were offered free PSA testing. Risk stratification guided follow-up: men with PSA >3 ng/mL or a positive FH were referred to urology; others were assigned 2- or 5-year recall based on PSA level. : By June 2025, 8558 men had enrolled (8.7% uptake), 6072 were eligible; 644 (10.6%) reported a positive FH. Among those tested, 58.4% had PSA < 1 ng/mL and were FH-negative, 25.8% had PSA > 1 and <3 ng/mL and were FH-negative, and 15.9% met referral criteria. Digital triage was efficient and ensured care continuity without burdening specialists. Participation varied by local health authority (ATS), depending on implementation context. Preliminary data show a 25.9% reduction in urology consultations and a 35% reduction in MRI use compared to standard care, with no biopsy rate increase. : The pilot demonstrates the technical feasibility, safety, low administrative burden, and potential sustainability of digital, risk-stratified prostate cancer screening. While participation was low without active invitations, early results support expansion with improved outreach. Lombardy's experience offers a scalable, EU-aligned model for broader implementation across Italy and other health systems seeking to balance early detection with resource efficiency.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기